Cargando…

Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia

BACKGROUND: Currently, there are no guidelines for the treatment of rheumatoid arthritis (RA) tailored to the context of the Kingdom of Saudi Arabia (KSA). Adaptation of guidelines accounts for contextual factors and becomes more efficient than de novo guideline development when relevant, good quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Khabsa, Joanne, Yaacoub, Sally, Omair, Mohammed A., Al Rayes, Hanan, Akl, Elie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563247/
https://www.ncbi.nlm.nih.gov/pubmed/37817088
http://dx.doi.org/10.1186/s12874-023-02031-2
_version_ 1785118297573818368
author Khabsa, Joanne
Yaacoub, Sally
Omair, Mohammed A.
Al Rayes, Hanan
Akl, Elie A.
author_facet Khabsa, Joanne
Yaacoub, Sally
Omair, Mohammed A.
Al Rayes, Hanan
Akl, Elie A.
author_sort Khabsa, Joanne
collection PubMed
description BACKGROUND: Currently, there are no guidelines for the treatment of rheumatoid arthritis (RA) tailored to the context of the Kingdom of Saudi Arabia (KSA). Adaptation of guidelines accounts for contextual factors and becomes more efficient than de novo guideline development when relevant, good quality, and up-to-date guidelines are available. The objective of this study is to describe the methodology used for the adolopment of the 2021 American College of Rheumatology (ACR) guidelines for the treatment of RA in the KSA. METHODS: We followed the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE)-ADOLOPMENT methodology. The adolopment KSA panel included relevant stakeholders and leading contributors to the original guidelines. We developed a list of five adaptation-relevant prioritization criteria that the panelists applied to the original recommendations. We updated the original evidence profiles with newly published studies identified by the panelists. We constructed Evidence to Decision (EtD) tables including contextual information from the KSA setting. We used the PanelVoice function of GRADEPro Guideline Development Tool (GDT) to obtain the panel’s judgments on the EtD criteria ahead of the panel meeting. Following the meeting, we used the PANELVIEW instrument to obtain the panel’s evaluation of the process. RESULTS: The KSA panel prioritized five recommendations, for which one evidence profile required updating. Out of five adoloped recommendations, two were modified in terms of direction, and one was modified in terms of certainty of the evidence. Criteria driving the modifications in direction were valuation of outcomes, balance of effects, cost, and acceptability. The mean score on the 7-point scale items of the PANELVIEW instrument had an average of 6.47 (SD = 0.18) across all items. CONCLUSION: The GRADE-ADOLOPMENT methodology proved to be efficient. The panel assessed the process and outcome positively. Engagement of stakeholders proved to be important for the success of this project. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-02031-2.
format Online
Article
Text
id pubmed-10563247
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105632472023-10-11 Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia Khabsa, Joanne Yaacoub, Sally Omair, Mohammed A. Al Rayes, Hanan Akl, Elie A. BMC Med Res Methodol Research BACKGROUND: Currently, there are no guidelines for the treatment of rheumatoid arthritis (RA) tailored to the context of the Kingdom of Saudi Arabia (KSA). Adaptation of guidelines accounts for contextual factors and becomes more efficient than de novo guideline development when relevant, good quality, and up-to-date guidelines are available. The objective of this study is to describe the methodology used for the adolopment of the 2021 American College of Rheumatology (ACR) guidelines for the treatment of RA in the KSA. METHODS: We followed the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE)-ADOLOPMENT methodology. The adolopment KSA panel included relevant stakeholders and leading contributors to the original guidelines. We developed a list of five adaptation-relevant prioritization criteria that the panelists applied to the original recommendations. We updated the original evidence profiles with newly published studies identified by the panelists. We constructed Evidence to Decision (EtD) tables including contextual information from the KSA setting. We used the PanelVoice function of GRADEPro Guideline Development Tool (GDT) to obtain the panel’s judgments on the EtD criteria ahead of the panel meeting. Following the meeting, we used the PANELVIEW instrument to obtain the panel’s evaluation of the process. RESULTS: The KSA panel prioritized five recommendations, for which one evidence profile required updating. Out of five adoloped recommendations, two were modified in terms of direction, and one was modified in terms of certainty of the evidence. Criteria driving the modifications in direction were valuation of outcomes, balance of effects, cost, and acceptability. The mean score on the 7-point scale items of the PANELVIEW instrument had an average of 6.47 (SD = 0.18) across all items. CONCLUSION: The GRADE-ADOLOPMENT methodology proved to be efficient. The panel assessed the process and outcome positively. Engagement of stakeholders proved to be important for the success of this project. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-02031-2. BioMed Central 2023-10-10 /pmc/articles/PMC10563247/ /pubmed/37817088 http://dx.doi.org/10.1186/s12874-023-02031-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Khabsa, Joanne
Yaacoub, Sally
Omair, Mohammed A.
Al Rayes, Hanan
Akl, Elie A.
Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
title Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
title_full Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
title_fullStr Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
title_full_unstemmed Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
title_short Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
title_sort methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the kingdom of saudi arabia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563247/
https://www.ncbi.nlm.nih.gov/pubmed/37817088
http://dx.doi.org/10.1186/s12874-023-02031-2
work_keys_str_mv AT khabsajoanne methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia
AT yaacoubsally methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia
AT omairmohammeda methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia
AT alrayeshanan methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia
AT akleliea methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia
AT methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia